In addition, we also observed substantial increase in the levels of activated RIPK1 and apoptosis in human NASH livers that showed reduced expression of UGDH (Supplementary Fig. 3f). The gene discussed is RIPK1; the disease is metabolic dysfunction-associated steatohepatitis.